Pharmacies Selling PSE: Remember to Train Employees and Self-Certify
FDA Law Blog
AUGUST 21, 2023
Investigators also found that the pharmacy sold pseudoephedrine (“PSE”) products but failed to self-certify in violation of the Combat Methamphetamine Act of 2005 (“CMEA”). Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act, Aug. 16, 2023 ( DOJ Press Release ). 21 U.S.C. §
52 
Let's personalize your content